SporeGen® Awarded EMI-TB Grant
- December 01, 2014
SporeGen® has been made a partner on the Horizon 2020 EMI-TB Grant focusing on developing innovative mucosal vaccines to TB, utilising the SporeGen® “SporeVax” technology. The grant is led by Dr. Rajko Reljic of St Georges University of London.